|
| Number of patients | Follow-up | Initial RT Dose (Gy) | Re-RT Dose (Gy) | Technique | Complete Response (%) | Grade 3 Toxicity (%) |
| Laramore et al. [2] | 13 | 9 mo - 5 yr | 40 - 50 | 40 - 50 | Electron | 61.5 | 0 |
| Phromratanaponge et al. [3] | 44 | 1 mo | 35 - 66 | 16 - 56 | EBRT + HT | 40.9 | 25 |
| Linthorst et al. [4] | 248 | 32 mo | 49 | 32 | EBRT + HT | 40 (5 yr) | 1 (5 yr) |
| Oldenborg et al. [5] | 78 | 64.2 mo | >50 | 32 | EBRT + HT | 78 (3 yr), 65 (5 yr) | 32 |
| Jones et al. [6] | 52 | 2 - 9 yr |
| 60 - 70 | EBRT | 42 | 2 |
| Jones et al. [6] | 56 | 2 - 9 yr |
| 30 - 66 | EBRT + HT | 66 | 3 |